Everts M - Search Results

1

Transductional targeting of adenovirus vectors for gene therapy.

Glasgow JN, Everts M, Curiel DT. Glasgow JN, et al. Among authors: everts m. Cancer Gene Ther. 2006 Sep;13(9):830-44. doi: 10.1038/sj.cgt.7700928. Epub 2006 Jan 27. Cancer Gene Ther. 2006. PMID: 16439993 Free PMC article. Review.

2

Mesothelin-mediated targeting of adenoviral vectors for ovarian cancer gene therapy.

Breidenbach M, Rein DT, Everts M, Glasgow JN, Wang M, Passineau MJ, Alvarez RD, Korokhov N, Curiel DT. Breidenbach M, et al. Among authors: everts m. Gene Ther. 2005 Jan;12(2):187-93. doi: 10.1038/sj.gt.3302404. Gene Ther. 2005. PMID: 15526007

3

Selective induction of tumor-associated antigens in murine pulmonary vasculature using double-targeted adenoviral vectors.

Everts M, Kim-Park SA, Preuss MA, Passineau MJ, Glasgow JN, Pereboev AV, Mahasreshti PJ, Grizzle WE, Reynolds PN, Curiel DT. Everts M, et al. Gene Ther. 2005 Jul;12(13):1042-8. doi: 10.1038/sj.gt.3302491. Gene Ther. 2005. PMID: 15789059

4

A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy.

Stoff-Khalili MA, Rivera AA, Glasgow JN, Le LP, Stoff A, Everts M, Tsuruta Y, Kawakami Y, Bauerschmitz GJ, Mathis JM, Pereboeva L, Seigal GP, Dall P, Curiel DT. Stoff-Khalili MA, et al. Among authors: everts m. Gene Ther. 2005 Dec;12(23):1696-706. doi: 10.1038/sj.gt.3302588. Gene Ther. 2005. PMID: 16034451

5

Employment of liver tissue slice analysis to assay hepatotoxicity linked to replicative and nonreplicative adenoviral agents.

Stoff-Khalili MA, Rivera AA, Le LP, Stoff A, Everts M, Contreras JL, Chen D, Teng L, Rots MG, Haisma HJ, Rocconi RP, Bauerschmitz GJ, Rein DT, Yamamoto M, Siegal GP, Dall P, Michael Mathis J, Curiel DT. Stoff-Khalili MA, et al. Among authors: everts m. Cancer Gene Ther. 2006 Jun;13(6):606-18. doi: 10.1038/sj.cgt.7700934. Cancer Gene Ther. 2006. PMID: 16410819

6

Directing adenovirus across the blood-brain barrier via melanotransferrin (P97) transcytosis pathway in an in vitro model.

Tang Y, Han T, Everts M, Zhu ZB, Gillespie GY, Curiel DT, Wu H. Tang Y, et al. Among authors: everts m. Gene Ther. 2007 Mar;14(6):523-32. doi: 10.1038/sj.gt.3302888. Epub 2006 Nov 30. Gene Ther. 2007. PMID: 17167498

7

Characterization of infectivity of knob-modified adenoviral vectors in glioma.

Paul CP, Everts M, Glasgow JN, Dent P, Fisher PB, Ulasov IV, Lesniak MS, Stoff-Khalili MA, Roth JC, Preuss MA, Dirven CM, Lamfers ML, Siegal GP, Zhu ZB, Curiel DT. Paul CP, et al. Among authors: everts m. Cancer Biol Ther. 2008 May;7(5):786-93. doi: 10.4161/cbt.7.5.5421. Cancer Biol Ther. 2008. PMID: 18756624

8

Genetic replacement of the adenovirus shaft fiber reduces liver tropism in ovarian cancer gene therapy.

Breidenbach M, Rein DT, Wang M, Nettelbeck DM, Hemminki A, Ulasov I, Rivera AR, Everts M, Alvarez RD, Douglas JT, Curiel DT. Breidenbach M, et al. Among authors: everts m. Hum Gene Ther. 2004 May;15(5):509-18. doi: 10.1089/10430340460745829. Hum Gene Ther. 2004. PMID: 15144580

9

Transductional targeting of adenoviral cancer gene therapy.

Everts M, Curiel DT. Everts M, et al. Curr Gene Ther. 2004 Sep;4(3):337-46. doi: 10.2174/1566523043346372. Curr Gene Ther. 2004. PMID: 15384947 Review.

10

In vivo analysis of a genetically modified adenoviral vector targeted to human CD40 using a novel transient transgenic model.

Izumi M, Kawakami Y, Glasgow JN, Belousova N, Everts M, Kim-Park S, Yamamoto S, Wang M, Le LP, Reynolds PN, Curiel DT. Izumi M, et al. Among authors: everts m. J Gene Med. 2005 Dec;7(12):1517-25. doi: 10.1002/jgm.806. J Gene Med. 2005. PMID: 16170831

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

140 results

Search Page